VICR vs. ABBV

Last updated Apr 1, 2026

Compare and contrast key facts about Vicor Corporation (VICR) and AbbVie Inc. (ABBV).

Performance

VICR vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vicor Corporation (VICR) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

VICR vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VICR Vicor Corporation	46.90%	126.82%	7.52%	-16.39%	-57.67%	37.69%	97.39%	23.63%	80.81%	38.41%
ABBV AbbVie Inc.	-4.05%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Fundamentals

EPS VICR : $2.40 ABBV : $2.38
PE Ratio VICR : 67.01 ABBV : 91.23
PS Ratio VICR : 10.67K ABBV : 6.30
Total Revenue (TTM) VICR : $452.70K ABBV : $61.16B
Gross Profit (TTM) VICR : $259.43K ABBV : $44.85B
EBITDA (TTM) VICR : $94.16M ABBV : $28.29B

Returns By Period

In the year-to-date period, VICR achieves a 46.90% return, which is significantly higher than ABBV's -4.05% return. Over the past 10 years, VICR has outperformed ABBV with an annualized return of 31.88%, while ABBV has yielded a comparatively lower 19.07% annualized return.

VICR

• 1D: 13.20%
• 1M: -20.06%
• YTD: 46.90%
• 6M: 223.81%
• 1Y: 244.16%
• 3Y*: 50.81%
• 5Y*: 12.76%
• 10Y*: 31.88%

ABBV

• 1D: 2.05%
• 1M: -6.29%
• YTD: -4.05%
• 6M: -4.63%
• 1Y: 7.29%
• 3Y*: 15.00%
• 5Y*: 19.40%
• 10Y*: 19.07%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

VICR vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VICR

VICR Risk / Return Rank: 96
VICR Sharpe Ratio Rank: 97
VICR Sortino Ratio Rank: 93
VICR Omega Ratio Rank: 94
VICR Calmar Ratio Rank: 97
VICR Martin Ratio Rank: 97

ABBV

ABBV Risk / Return Rank: 50
ABBV Sharpe Ratio Rank: 52
ABBV Sortino Ratio Rank: 44
ABBV Omega Ratio Rank: 44
ABBV Calmar Ratio Rank: 56
ABBV Martin Ratio Rank: 55

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VICR vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vicor Corporation (VICR) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VICR	ABBV	Difference
Sharpe ratio Return per unit of total volatility	3.22	0.27	+2.95
Sortino ratio Return per unit of downside risk	3.20	0.54	+2.66
Omega ratio Gain probability vs. loss probability	1.48	1.07	+0.41
Calmar ratio Return relative to maximum drawdown	7.27	0.53	+6.74
Martin ratio Return relative to average drawdown	22.50	1.17	+21.33
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VICR vs. ABBV - Sharpe Ratio Comparison

The current VICR Sharpe Ratio is 3.22, which is higher than the ABBV Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of VICR and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	VICR	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.22	0.27	+2.95
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.18	0.86	-0.68
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.51	0.74	-0.23
Sharpe Ratio (All Time) Calculated using the full available price history	0.12	0.74	-0.62

Correlation

The correlation between VICR and ABBV is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

VICR vs. ABBV - Dividend Comparison

VICR has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.06%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
VICR Vicor Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ABBV AbbVie Inc.	3.06%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%

Drawdowns

VICR vs. ABBV - Drawdown Comparison

The maximum VICR drawdown since its inception was -92.26%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for VICR and ABBV.

Drawdown Indicators

	VICR	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-92.26%	-45.09%	-47.17%
Max Drawdown (1Y) Largest decline over 1 year	-32.01%	-16.74%	-15.27%
Max Drawdown (5Y) Largest decline over 5 years	-80.47%	-21.92%	-58.55%
Max Drawdown (10Y) Largest decline over 10 years	-80.47%	-45.09%	-35.38%
Current Drawdown Current decline from peak	-23.04%	-9.64%	-13.40%
Average Drawdown Average peak-to-trough decline	-58.73%	-10.70%	-48.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.34%	8.12%	+2.22%

Volatility

VICR vs. ABBV - Volatility Comparison

Vicor Corporation (VICR) has a higher volatility of 34.68% compared to AbbVie Inc. (ABBV) at 7.57%. This indicates that VICR's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VICR	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	34.68%	7.57%	+27.11%
Volatility (6M) Calculated over the trailing 6-month period	60.89%	19.03%	+41.86%
Volatility (1Y) Calculated over the trailing 1-year period	76.43%	27.12%	+49.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.79%	22.61%	+47.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	62.31%	25.71%	+36.60%

Financials

VICR vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Vicor Corporation and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

VICR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Vicor Corporation reported a gross profit of -199.75M and revenue of -344.98M. Therefore, the gross margin over that period was 57.9%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a gross profit of 13.96B and revenue of 16.62B. Therefore, the gross margin over that period was 84.0%.

VICR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Vicor Corporation reported an operating income of -66.06M and revenue of -344.98M, resulting in an operating margin of 19.2%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported an operating income of 5.81B and revenue of 16.62B, resulting in an operating margin of 35.0%.

VICR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Vicor Corporation reported a net income of 46.53K and revenue of -344.98M, resulting in a net margin of -0.0%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a net income of 1.82B and revenue of 16.62B, resulting in a net margin of 10.9%.